Where is the next SARS-CoV-2 variant of concern?

John J Dennehy¹, Ravindra K Gupta², William P Hanage³, Marc C Johnson⁴, Thomas P Peacock⁵

Affiliations

¹ Biology Department, Queens College, City University of New York, New York, NY 11367, USA; The Graduate Center, City University of New York, New York, NY 11367, USA. Electronic address: john.dennehy@qc.cuny.edu.
² Department of Medicine, University of Cambridge, Cambridge, UK.
³ Center for Communicable Disease Dynamics, Harvard T H Chan School of Public Health, Boston, MA, USA.
⁴ Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, Columbia, MO, USA.
⁵ Department of Infectious Disease, Imperial College London, London, UK.

PMID: 35598619
PMCID: PMC9119661
DOI: 10.1016/S0140-6736(22)00743-7

Where is the next SARS-CoV-2 variant of concern?

John J Dennehy et al. Lancet. 2022.

. 2022 May 21;399(10339):1938-1939.

doi: 10.1016/S0140-6736(22)00743-7.

Authors

John J Dennehy¹, Ravindra K Gupta², William P Hanage³, Marc C Johnson⁴, Thomas P Peacock⁵

Affiliations

¹ Biology Department, Queens College, City University of New York, New York, NY 11367, USA; The Graduate Center, City University of New York, New York, NY 11367, USA. Electronic address: john.dennehy@qc.cuny.edu.
² Department of Medicine, University of Cambridge, Cambridge, UK.
³ Center for Communicable Disease Dynamics, Harvard T H Chan School of Public Health, Boston, MA, USA.
⁴ Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, Columbia, MO, USA.
⁵ Department of Infectious Disease, Imperial College London, London, UK.

PMID: 35598619
PMCID: PMC9119661
DOI: 10.1016/S0140-6736(22)00743-7

No abstract available

PubMed Disclaimer

References

1. Hill V, Du Plessis L, Peacock TP, et al. The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK. bioRxiv. 2022 doi: 10.1101/2022.03.08.481609. published online March 8. (preprint). - DOI - PMC - PubMed
1. Moran E, Cook T, Goodman AL, et al. Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials. Lancet Infect Dis. 2021;21:1345–1347. - PMC - PubMed
1. Wilkinson SAJ, Richter A, Casey A, et al. Recurrent SARS-CoV-2 mutations in immunodeficient patients. medRxiv. 2022 doi: 10.1101/2022.03.02.22271697. published online March 2. (preprint). - DOI - PMC - PubMed
1. Harvey WT, Carabelli AM, Jackson B, et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021;19:409–424. - PMC - PubMed
1. Rockett R, Basile K, Maddocks S, et al. Resistance mutations in SARS-CoV-2 delta variant after sotrovimab use. N Engl J Med. 2022;386:1477–1479. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Supplementary concepts

Actions

Grants and funding

U01 DA053893/DA/NIDA NIH HHS/United States

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Where is the next SARS-CoV-2 variant of concern?

Affiliations

Where is the next SARS-CoV-2 variant of concern?

Authors

Affiliations

References

Publication types

MeSH terms

Substances

Supplementary concepts

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous